Trinity Biotech PLC (TRIB): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand trinitybiotech.com (TRIB)

Investments in sustainable packaging and energy efficiency are impacting cash flows, as confirmed by the price/sales multiple of Trinity Biotech plc (TRIB), where the parameter stands at 0.10. Asset dynamics on the chart correlate with management's new course toward debt reduction. Growth prospects are based on a B2B model for reagent supplies, which generates stable income under strict medical supervision.

Trinity Biotech Corp (TRIB): Price-to-Revenue Ratio from 07/04/2022 to 11/13/2026

Trinity Biotech plc (TRIB) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price trinitybiotech.com|TRIB - Price Target Chart
- stock exchange capitalization data:
Market Value Trinity Biotech Corp|TRIB - Enterprise Value
- book capitalization indicators:
Net Assets per Share Trinity Biotech|TRIB - Company Book Value|Capitalization to Book Value Ratio trinitybiotech.com|TRIB - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Trinity Biotech plc|TRIB - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio trinitybiotech.com|TRIB - Company Total Debt|Debts to Book Value Trinity Biotech Corp|TRIB - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Trinity Biotech|Quick Liquidity trinitybiotech.com
- net income and valuation ratios data:
TRIB - Net Profit|Company Profit Forecast Trinity Biotech plc|TRIB - Price to Earnings Ratio|Projected Price to Earnings Ratio trinitybiotech.com|TRIB - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Trinity Biotech Corp|TRIB - Operating profit EBITDA|Net earnings per one share for the last twelve months Trinity Biotech|TRIB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months trinitybiotech.com|TRIB - Earnings growth in current year|Expected earnings per share trend next year Trinity Biotech plc
- total revenue and sales volume data:
TRIB - Company Sales|Company Future Revenue trinitybiotech.com|TRIB - Price-to-Revenue Ratio|Future Price to Revenue Trinity Biotech Corp
Summary company analytics:TRIB - Trinity Biotech PLC
Core merchandise of Trinity Biotech Corp

Investors are evaluating the prospects of Trinity Biotech plc (TRIB) through the ratio of market capitalization to annual revenue. This multiple determines the cost of one dollar of sales, making it possible to identify business overvaluation regardless of current earnings. By analyzing the price-to-sales multiple history, one can track the effectiveness of asset restructuring and cost optimization. A decline in this metric amid the transition to profitable diagnostic segments would confirm the fundamental undervaluation of the shares.

Who Trinity Biotech plc competes with

Market Cap to Sales Volume A|Price-to-Revenue Ratio Quest Diagnostics Incorporated DGX|Market Capitalization-to-Revenue Ratio ILMN|Cologuard - P/S Multiple|Price-to-Revenue Coefficient Revvity Corp RVTY|Bio-Rad Laboratories (BIO) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio NNNN|SHC (Sotera Health) - P/S Multiple|Quidel Corporation (QDEL) - Price-to-Revenue Coefficient|Market Cap to Revenue OPK (OPKO Corp)|Market Cap to Sales Volume CDNA|Maravai LifeSciences - Market Cap to Revenue|fulgentgenetics.com (FLGT) - Price to Sales|LAB: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio CTKB (Cytek Biosciences Inc)|OSUR: P/S Multiple|XGN (Exagen) - Price-to-Revenue Ratio|MDXH (MDxHealth SA) - P/S Multiple|luciddx.com (LUCD) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Prenetics Global (PRE)|IMDX - Price to Sales|ProPhase - Market Cap to Revenue|Market Cap to Sales Volume AIMD (Ainos Corporation)|Co-Diagnostics, Inc. - P/S Multiple|Price to Sales heartsciences.com|BMRA: P/S Multiple|Market Cap to Revenue Cardio Diagnostics Holdings|ONCO (Onconetix Corp) - P/S Multiple|VRAX: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue BJDX (Bluejay Diagnostics)|AWH (aspirawh.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Accelerate Diagnostics, Inc. AXDX|CNTG (Centogene N.V.) - Price-to-Sales Ratio|ENZ - Price-to-Revenue Ratio|FRES: Price-to-Revenue Ratio|GENE: P/S Multiple|Market Cap to Revenue 23andme.com|Market Cap to Revenue PMD